American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington D.C: American Psychiatric Association; 1994.
Bryson SE, Smith IM.
Epidemiology of autism: Prevalence, associated characteristics and implications for research and service delivery. Mental Retard Dev Disab Res Rev. 1998; 000:1–7.
Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Measles-mumps-rubella vaccine and autistic spectrum disorder: a hypothesis only. Paediatr Child Health. 2001; 6:387–91.
Is there an epidemic of autism?
Pediatrics. 2001; 107:411–2.
Roberts W, Harford M.
Immunization and children at risk for autism. Paediatr Child Health. 2002; 7:623–32.
American Academy of Pediatrics Committee on Infectious Diseases. Red Book. 26th ed. Elk Grove Village Il: American Academy of Pediatrics; 2003.
Filipek PA, Accardo JA, Baranek GT, Cook EH Jr, Dawson G, Gordon B, et al.
The screening and diagnosis of autistic spectrum disorders. J Aut Dev Dis. 1999; 29:439–84.
Wakefield AJ, Murch SH, Linnell AJ, Casson DM, Malik M, Berelowitz M, et al.
Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 1998; 351:637–41.
Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ.
Is measles vaccination a risk factor for inflammatory bowel disease?
Lancet. 1995; 345:1071–4.
Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al.
Enterocolitis in children with developmental disorders. Am J Gastro. 2000; 95:2285–95.
Halsey N, Hyman S.
Conference writing panel. Measles, Mumps and Rubella Vaccine and Autism Spectrum Disorder. Report from the New Challenges in Childhood Immunization Conference convened at Oak Brook, Illinois, June 12-13, 2001. Pediatrics. 2001; 107:1–23.
Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, et al.
Evidence of persistent measles virus infection in Chron’s disease. J Med Virol. 1993; 39:345–53.
Uhlman V, Martin CM, Shiels O, Pilkington L, Silva I, Killalea A, et al.
Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 2002; 55:84–90.
Afzal MA, Armitage E, Begley J, Bentley ML, Minor PD, Ghosh S
Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. J Med Virol. 1998; 55:243–9.
Iizuka M, Itou H, Chiba M, Shirasaka T, Watanabe S, et al.
The MMR question. Lancet. 2000; 356:160.
Singh VK, Lin SX, Newell E, Nelson C.
Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci. 2002; 9: 359–64.
Deer Brian. “Revealed: MMR reseach scandal. The Sunday Times (London). 2004 Feb 22.
Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, et al.
Retraction of an interpretation. Lancet. 2004; 363:750.
Wilson K, Mills E, Ross C, McGowan J, Jaddad A.
Association of autistic spectrum disorder and the measles, mumps and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med. 2003; 157:628–34.
Madsen KM, Hvid A, Vestergaard M, Schendel D, Wohlfahrt J
Thornsen P, et al.
A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002; 347:1477–82.
Taylor B, Miller E, Farringtom CP, Petropoulos MC, Favot-Mayaud I, Li J, et al.
Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999; 353:2026–29.
Kaye JA, Melero-Montes MM, Jick H.
Mumps, measles and rubella vaccine and the incidence of autism recorded by general practioners: a time trend analysis. BMJ. 2001; 322:460–3.
Dales L, Hammer SJ, Smith NJ.
Time trends in autism and MMR immunization coverage in California. JAMA. 2001; 286:1183–5.
Honda H, Shimizu Y, Rutter M.
No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psych Psychol. 2005; 46:572–79.
Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al.
MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004; 364:963–9.
Makela A, Nuorti JP, Petola H.
Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002; 110:957–63.
Fombonne E, Chakrabart S.
No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001; 108:1–8.
Petola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M.
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998; 351: 1327–8.
Black C, Kaye JA, Jick H.
Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Database. BMJ. 2002; 325:419–21.
Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J.
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002; 324:393–6.
Parker SK, Schwartz B, Todd J, Pickering LK.
Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004; 114:793–804.
US Environmental Protection Agency Mercury study report to congress: volume IV: an assessment of exposure to mercury in the United States. Available from: www.epa.gov/mercury. [Cited: 2005 Aug 24].
Health Canada. Exposure to thimerosal in vaccines used in Canadian infant immunization programs with respect to risk of neurodevelopmental disorders. Can Commun Dis Rep
Nelson KB, Bauman ML.
Thimerosal and autism?
Pediatrics. 2003; 111: 674–9.
Kerper LE, Ballagtori N, Clarkson TW.
Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol. 1992;262:R761–5.
Bernard S, Enayati A, Redwood L, Roger H, Binstock T.
Autism: a novel form of mercury poisoning. Med Hypotheses. 2001; 56:462–71.
Ip P, Wong V, Ho M, Lee J, Wong W.
Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004; 19:431–4.
Pichichero ME, Cernichiari E, Lopreiato J, Treanor J.
Mercury concentrations and metabolism in infants receiving vaccines containing thimerosall: a descriptive study. Lancet. 2002; 360:1737–41.
Holmes AS, Blaxill MF, Haley BE.
Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol. 2003; 22:277–85.
Geier MR, Geier DA.
Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med. 2003; 228:660–4.
Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al.
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003; 112:1039–48.
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M.
Association between thimerosal-containing vaccines and autism. JAMA. 2003; 290:1763–6.
Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.
Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004; 114:584–91.
Madsen K, Lauritsen M, Pedersen C, Thorsen P, Plesner AM, Anderson PH, et al.
Thimerosal and the occurrence of autism? Negative ecological evidence from Danish population-based data. Pediatrics. 2003; 112:604–6.
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al.
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004; 80:1611–7.
James SJ, Slikker W, Melnyk S, New E, Pogribna M, Jernigan S.
Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology. 2005; 26:1–8.
Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psych. 2004; 1-13.
Shannon M, Levy S, Sandler A. Chelation therapy neither safe nor effective as autism treatment. AAP news. 2001:63.
World Health Organization. Global Advisory Committee on Vaccine Safety, 16-17 December 2002: MMR and autism. Weekly Epidemiological Record Available from: http://www.who.int/wer/2003/en/wer7804.pdf [Cited: 2005 Aug 24].
Jansen VA, Stollenwerk N, Jensen HJ, Ramsay Me, Edmunds WJ, Rhodes CJ.
Measles outbreaks in populations with declining vaccine uptake. Science. 2003; 301:804.